SNAP-8

SNAP-8 (acetyl octapeptide-3) is an extension of the hexapeptide argireline, developed for topical cosmetic formulations as a research alternative to neuromodulator injections for expression lines.

The peptide mimics the N-terminal end of SNAP-25 and competes for a position in the SNARE complex, reducing the efficiency of vesicle docking required for acetylcholine release at the neuromuscular junction. Reduced catecholamine and acetylcholine release is thought to soften contraction of superficial mimetic muscles.

Store the sealed vial at 2-8 °C, protected from light. Reconstituted or formulated solutions should be refrigerated and used within four weeks. Avoid freeze-thaw cycles and do not expose the peptide to strongly oxidizing cosmetic actives during formulation.

• Sealed lyophilized vial
• Bacteriostatic or distilled water depending on formulation route
• Sterile mixing vessel and pipette
• Base cream or serum vehicle for topical processing
• 70% isopropyl alcohol swabs
• Labels and a formulation logbook

Manufacturer-sponsored in vivo studies report reductions in wrinkle depth of approximately 25-35% over four weeks with topical application at 10%. Independent peer-reviewed dermatological data are limited. Topical application is generally well tolerated; the peptide is not intended for injection.

Wash your hands, then disinfect the vial septum and the injection site with 70% isopropyl alcohol and allow both to air dry. Draw up the intended volume, remove air bubbles and pinch a subcutaneous skin fold. Insert at a 45-90° angle depending on fat thickness, aspiration is not required for subcutaneous administration, and inject slowly. Withdraw the needle, apply light pressure and discard the needle in a sharps container. Rotate injection sites systematically (abdominal quadrants, flanks, thighs) to prevent lipohypertrophy and local irritation.

Peptide research protocols are studied against a background of adequate protein intake (approximately 1.6-2.2 g/kg/day in the training literature), consistent sleep of 7-9 hours, and controlled training load. Sleep deprivation and chronic psychological stress both dampen growth hormone pulsatility and disrupt tissue remodeling, complicating the interpretation of any observed effect. Alcohol, smoking and large caloric deficits are likewise documented modifiers of recovery outcomes.

1. Blanes-Mira C. et al. A synthetic hexapeptide with antiwrinkle activity. Int J Cosmet Sci, 2002.
2. Wang Y. et al. The anti-wrinkle efficacy of argireline. J Cosmet Laser Ther, 2013.
3. Lupo M.P., Cole A.L. Cosmeceutical peptides. Dermatol Ther, 2007.